Q2 2021 Holdings
Filed 2021-08-16 | 84 holdings | $22.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $7.3M | 91,529 | 32.8% |
| Accuray Inc(ARAY) | COM | 004397105 | $4.3M | 941,800 | 19.2% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $3.3M | 119,700 | 14.9% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $2.3M | 80,000 | 10.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $1.8M | 223,554 | 8.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $1.8M | 100,000 | 7.9% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $939.0K | 7,137 | 4.2% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $131.9K | 13,680,554 | 0.6% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $27.3K | 314,360 | 0.1% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $19.1K | 510,756 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $18.3K | 207,911 | 0.1% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $10.6K | 732,345 | 0.0% |
| Morphic Holding Inc | COM | 61775R105 | $10.4K | 181,467 | 0.0% |
| Translate BIO Inc | COM | 89374L104 | $10.4K | 376,993 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $9.7K | 170,306 | 0.0% |
| Biohaven Pharmaceuticals Hold(BHVN) | COM | G11196105 | $9.1K | 94,100 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $9.0K | 21,138 | 0.0% |
| Affimed N V | COM | N01045108 | $8.2K | 964,857 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $8.2K | 119,615 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $8.1K | 306,320 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.6K | 406,535 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $7.2K | 73,655 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $7.0K | 331,661 | 0.0% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $7.0K | 1,031,880 | 0.0% |
| Ishares TR Nasdaq Biotech(IBB) | ETF | 464287556 | $6.7K | 40,900 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $6.7K | 209,731 | 0.0% |
| Cardiovascular Systems Inc(CSIIEUR) | COM | 141619106 | $6.4K | 149,700 | 0.0% |
| F-Star Therapeutics Inc | COM | 30315R107 | $6.1K | 714,285 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $6.0K | 53,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $5.4K | 77,675 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $5.3K | 2,379,392 | 0.0% |
| Luminex Corp | COM | 55027E102 | $5.1K | 139,091 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $4.6K | 289,040 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $4.5K | 315,000 | 0.0% |
| Neuronetics Inc(STIM) | COM | 64131A105 | $4.1K | 253,717 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $3.9K | 376,281 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $3.7K | 47,852 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $3.7K | $4,000,000 | 0.0% |
| Venus Concept Inc | COM | 92332W105 | $3.7K | 1,185,100 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $3.6K | 1,126,613 | 0.0% |
| Merus N V | COM | N5749R100 | $3.3K | 157,841 | 0.0% |
| Redhill Biopharma LTD | SPONSORED ADS | 757468103 | $3.1K | 455,933 | 0.0% |
| FS Development Corp II | COM CL A | 30318F100 | $3.0K | 300,000 | 0.0% |
| Hookipa Pharma Inc | COM | 43906K100 | $3.0K | 322,124 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.7K | 447,400 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $2.5K | 147,702 | 0.0% |
| Natus Medical Inc | COM | 639050103 | $2.5K | 95,653 | 0.0% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $2.2K | 603,042 | 0.0% |
| Aslan Pharmaceuticals LTD | ADS | 04522R101 | $2.2K | 677,500 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $2.2K | 510,386 | 0.0% |